17 June 2021 From code to clinic: the potential of AI in healthcare Healthcare is not yet fully embracing the potential of AI. The entire…
19 April 2021 Ensuring resilience and sustainability in healthcare The pandemic has exposed the inequalities and weaknesses within some of the…
10 February 2021 Struggling to attract Life Science talents during the pandemic? EY is reaping the benefits of going virtual with a booth at…
2 October 2020 Biotech success deserves to be in the spotlight Biotech is a major pillar of the Swiss economy, part of a…
23 January 2020 EY at FutureHealth Basel 2020 – Join the Conversation! It is a tremendous honor for EY to be participating in FutureHealth,…
6 May 2019 «Die Schweiz ist eine gute ‘innovation engine’» Am 7. Mai trifft sich die Industrie zum Swiss Biotech Day. Im…
28 January 2019 Life Sciences 4.0 – the next step in evolution? Life sciences companies must consider how to participate in emerging care platforms….
16 August 2018 Schweizer Firmen investieren weltweit am meisten in Forschung und E... 6,6 Prozent des Umsatzes investieren Schweizer Firmen durchschnittlich in Forschung und Entwicklung…
7 May 2018 What a year for the Swiss biotech sector! A record-breaking 1.6 billion francs of new capital, the role of the…